Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience. (17th December 2018)

• Record Type: Journal Article
• Authors: Woltsche, N.; Pichler, N.; Wolf, I.; Di Meo, N.; Zalaudek, I.
• Is Part Of: Journal of the European Academy of Dermatology and Venereology. Volume 33:Number 4(2019)
• Page Start: e144
• Page End: e145
• Publication Date: 2018-12-17
• Subjects: Dermatology -- Periodicals; Sexually transmitted diseases -- Periodicals; 616.5
• DOI: 10.1111/jdv.15367
• Languages: English
• ISSNs: 0926-9959

Abstract

Abstract : Linked article: This article is commented on by M. Scalvenzi et al ., pp. e146–e147 in this issue. To view this article visithttps://doi.org/10.1111/jdv.15469 .